Article
Acetylcysteine synergizes PD-1 blockers against colorectal cancer progression by promoting TCF1+PD1+CD8+T cell differentiation
2024-06-11
Abstract excerpt
<title>Abstract</title> <p>PD-1 blockade is essential in treating progressive colorectal cancer (CRC). However, some CRC patients do not respond well to immunotherapy, possibly due to the exhaustion of CD8<sup>+</sup> T cells in the tumor microenvironment. Acetylcysteine (NAC) can reduce CD8<sup>+</sup> T cell exhaustion in vitro and induce their differentiation into long-lasting phenotypes, thus enhancing the an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4ba9cc5f-1c5d-55f6-a642-08697ef7d8af
- DOI
- 10.21203/rs.3.rs-4458393/v1
